Mediflora Producer Company(Under Part Ixa Of The Companies Act 1956) Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 19-12-2024
- Paid Up Capital ₹ 3.35 M
as on 19-12-2024
- Company Age 20 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
About Mediflora Producer Company(Under Part Ixa Of The Companies Act 1956)
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 3.35 M, as per Ministry of Corporate Affairs (MCA) records.
Vijayan Pullaykodi, Santhanavalli Rajen, Lara Sreedhar, and One other member serve as directors at the Company.
- CIN/LLPIN
U01409KL2004PTC017361
- Company No.
017361
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ernakulam
Industry
Company Details
- Location
Palakkad, Kerala, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Mediflora Producer Company(Under Part Ixa Of The Companies Act 1956)?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreedhar Mullasseri  | Managing Director | 05-May-2018 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vijayan Pullaykodi | Director | 12-Jun-2019 | Current |
| Santhanavalli Rajen | Director | 12-Jun-2019 | Current |
| Lara Sreedhar | Director | 05-May-2018 | Current |
Financial Performance of Mediflora Producer Company(Under Part Ixa Of The Companies Act 1956).
Mediflora Producer Company Limited (Under Part Ixa Of The Companies Act 1956), for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Mediflora Producer Company(Under Part Ixa Of The Companies Act 1956)?
In 2017, Mediflora Producer Company(Under Part Ixa Of The Companies Act 1956) had a promoter holding of 93.43% and a public holding of 6.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Mediflora Producer Company(Under Part Ixa Of The Companies Act 1956)?
Unlock and access historical data on people associated with Mediflora Producer Company(Under Part Ixa Of The Companies Act 1956), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Mediflora Producer Company(Under Part Ixa Of The Companies Act 1956), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mediflora Producer Company(Under Part Ixa Of The Companies Act 1956)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
